Jump Financial »

Keros Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $900k 16k 58.07
2024-06-30 $625k 14k 45.70
2023-06-30 $293k 7.3k 40.18
2022-09-30 $379k 8.3k 45.45
2022-06-30 $564k 22k 25.64

More positions owned by Jump Financial

SPDR Dow Jones Industrial Average ETF Trust Etf (DIA)
Invesco QQQ Trust Series 1 Etf (QQQ)
POSCO Holdings Depositary Receipt (PKX)
Vanguard S&P 500 ETF Etf (VOO)
VanEck Semiconductor ETF Etf (SMH)
CME Group Common Stock (CME)
iShares 20 Year Treasury Bond ETF Etf (TLT)
Tesla Common Stock (TSLA)
Intercontinental Exchange Common Stock (ICE)
Technology Select Sector SPDR Fund Etf (XLK)
Microsoft Corp Common Stock (MSFT)
Alphabet Common Stock (GOOGL)
Netflix Common Stock (NFLX)
SPDR S&P 500 ETF Trust Etf Call Option (SPY)
Eli Lilly & Co Common Stock (LLY)

View all positions for Jump Financial

Top funds holding Keros Therapeutics

FMR
BlackRock
Alkeon Capital Management
Vanguard Group
Darwin Global Management
T. Rowe Price Associates
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
TCG Crossover Management
Leucadia National Corporation
Holocene Advisors
Woodline Partners
Geode Capital Management
Citadel Advisors

View all funds holding Keros Therapeutics